397 related articles for article (PubMed ID: 26872765)
1. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
Wu GX; Goldstein L; Kim JY; Raz DJ
Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
[TBL] [Abstract][Full Text] [Related]
2. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
[TBL] [Abstract][Full Text] [Related]
3. Lung carcinoma in former smokers.
Tong L; Spitz MR; Fueger JJ; Amos CA
Cancer; 1996 Sep; 78(5):1004-10. PubMed ID: 8780538
[TBL] [Abstract][Full Text] [Related]
4. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
[TBL] [Abstract][Full Text] [Related]
5. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
[TBL] [Abstract][Full Text] [Related]
6. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
[TBL] [Abstract][Full Text] [Related]
8. Trends in Subpopulations at High Risk for Lung Cancer.
Yang P; Wang Y; Wampfler JA; Xie D; Stoddard SM; She J; Midthun DE
J Thorac Oncol; 2016 Feb; 11(2):194-202. PubMed ID: 26811226
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
11. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
[TBL] [Abstract][Full Text] [Related]
12. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
15. Benefits and Challenges of Lung Cancer Screening in Older Adults.
Fabrikant MS; Wisnivesky JP; Marron T; Taioli E; Veluswamy RR
Clin Ther; 2018 Apr; 40(4):526-534. PubMed ID: 29573852
[TBL] [Abstract][Full Text] [Related]
16. Web-based survey on smoking cessation behaviors of current and former smokers in Japan.
Igarashi A; Negishi S; Goto R; Suwa K
Curr Med Res Opin; 2014 Oct; 30(10):1911-21. PubMed ID: 24960146
[TBL] [Abstract][Full Text] [Related]
17. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
[TBL] [Abstract][Full Text] [Related]
18. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
Kim EY; Shim YS; Kim YS; Lee SP; Ko KD; Choi WJ
PLoS One; 2019; 14(10):e0224224. PubMed ID: 31639166
[TBL] [Abstract][Full Text] [Related]
19. Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review.
White LJ; Kaur A; Lapel RT; E Boswell G; Luceri RE; Parrish JS; Seda G
Mil Med; 2020 Jun; 185(5-6):e864-e869. PubMed ID: 31925432
[TBL] [Abstract][Full Text] [Related]
20. Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility.
Kukhareva PV; Caverly TJ; Li H; Katki HA; Cheung LC; Reese TJ; Del Fiol G; Hess R; Wetter DW; Zhang Y; Taft TY; Flynn MC; Kawamoto K
J Am Med Inform Assoc; 2022 Apr; 29(5):779-788. PubMed ID: 35167675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
